Array (ARRY) Q4 2025 earnings review
Record Orderbook and 40% Annual Growth Overshadowed by a Brutal Q4 Collapse
Array finished 2025 with strong full-year top-line numbers, growing revenue by 40% YoY to $1.28 billion and expanding its orderbook to a record $2.2 billion. However, Q4 itself was a disaster. Revenue fell 18% YoY to $226 million, and profitability cratered under the weight of a $102.6 million goodwill impairment and a $29.5 million inventory obsolescence charge. Adjusted EBITDA shrank to a mere $11.2 million, exposing severe operational deleverage during seasonal volume troughs. While 2026 guidance projects a return to growth ($1.45B midpoint), the severe H2-weighted tilt (40:60) and a weak Q1 2026 outlook highlight persistent regulatory uncertainty that is delaying customer commitments.
🐂 Bull Case
The backlog expanded to $2.2 billion (inclusive of $100 million from the APA acquisition). The shift toward Tier 1 customers (IPPs and utilities) offers structural predictability once near-term regulatory hurdles clear.
Full-year volume growth of 35% significantly outpaced broader industry trends, validating the company's technical sales approach and the high demand for its domestic content-compliant products.
🐻 Bear Case
Q4 Adjusted EBITDA collapsed 75% YoY. Even excluding one-time write-downs, Adjusted Gross Margin compressed to 24.5% from 29.8% a year ago, reflecting extreme sensitivity to volume fluctuations.
A massive $102.6 million goodwill impairment for the 2022 STI acquisition and a $29.5 million charge to phase out non-SmarTrack compatible inventory reveal a costly track record of legacy missteps.
⚖️ Verdict: ⚪
Neutral. The long-term fundamentals and 2026 revenue guidance look stable, but the severity of the Q4 margin contraction and the expectation of an extremely weak Q1 2026 mean investors must weather significant near-term volatility.
Key Themes
Contradictory Narrative: "Exceptional Year" vs Q4 Margin Collapse
Management labeled 2025 an "exceptional year" due to annual top-line growth. Reversing this positive narrative, Q4 data exposes a severe profitability issue. Adjusted EBITDA plummeted to $11.2 million, representing a meager 5.0% margin compared to 16.4% in 24Q4 and 18.3% in 25Q3. This collapse suggests that when volume drops, Array lacks the pricing power or fixed-cost flexibility to protect its bottom line.
Macro and Regulatory Uncertainty Suppressing Near-Term Bookings
The implementation of the One Big Beautiful Bill (OBBB) Act and broader regulatory shifts are disrupting customer timelines. This uncertainty is causing a booking "air pocket," which is visible in the highly skewed 2026 guidance (40:60 split toward the second half) and a surprisingly weak Q1 2026 revenue forecast of ~$200 million.
APA Solar Integration and Balance of System Expansion
The APA Solar acquisition is pacing well, successfully contributing $100 million to the $2.2 billion orderbook. By integrating engineered foundations with fixed-tilt and tracker solutions, Array is actively increasing its share of wallet per project. This diversification is a key driver for structural margin improvement as cross-selling scales in 2026.
DuraTrack Global Expansion & Domestic Dominance
Array successfully expanded its market-proven DuraTrack technology internationally, capturing yield-advantaged demand. Domestically, its flexible supply chain allows it to deliver 100% U.S. content trackers, sheltering the company from import tariffs while allowing customers to fully capture IRA incentives.
Costly Phase-Outs of Legacy Technology
Innovation is moving fast, but it is leaving a trail of dead capital. The company took a $29.5 million inventory valuation charge specifically to phase out STI H250 inventory because it is not compatible with the flagship SmarTrack software suite. While necessary for portfolio optimization, it highlights the high cost of rapid technological transitions.
Other KPIs
Decelerating from the $135.4 million generated in FY 2024. Operating cash flow fell by roughly 34% YoY to $101.8 million, weighed down by working capital requirements associated with executing 35% higher volume. The company also absorbed a $164.9 million cash outflow for the APA acquisition, partially funded by a flexible debt structure.
Total debt remains relatively stable YoY ($677.3M at the end of 2024). The company successfully optimized its capital structure during the year (issuing $345M in convertible notes to retire high-cost term loans), leaving it with $244.4 million in cash and equivalents. This provides adequate runway despite the GAAP net losses.
Guidance
Accelerating from Q4's run-rate but Decelerating compared to the 40% full-year growth of 2025. The midpoint ($1.45 billion) implies ~13% YoY growth. Management explicitly noted a 40:60 split between the first and second halves of the year due to regulatory-driven contracting delays.
Decelerating aggressively. This represents an 11% sequential drop from an already weak Q4, and a 33% YoY decline compared to Q1 2025's $302.4 million. It is the clearest numerical proof that customer hesitancy around the OBBB Act is causing a near-term freeze in project kick-offs.
Stable. The midpoint of $215 million implies a 14.6% YoY growth rate over 2025's $187.6 million, closely tracking the projected 13% top-line growth. Q1 2026 EBITDA is expected to decline slightly from Q4 2025 levels, meaning the vast majority of 2026 profits must be generated in the back half of the year.
Stable. The $0.70 midpoint implies a 4.5% YoY increase compared to 2025's $0.67. Note that management excluded several non-GAAP adjustments from guidance estimates due to unpredictability, which could materially alter final GAAP EPS.
Key Questions
Backlog Conversion Confidence
With Q1 2026 revenue guided to just ~$200 million and a heavy reliance on a 40:60 H1/H2 split, what specific milestones or regulatory clarifications are required for customers to release the back-half volume from the $2.2 billion orderbook?
Anatomy of the Q4 Margin Collapse
Adjusted gross margin compressed to 24.5% in Q4. How much of this 530 bps YoY decline was driven by raw pricing pressure versus the under-absorption of fixed costs due to lower volumes?
Legacy STI Exposure
The $102.6 million goodwill impairment indicates severe ongoing underperformance of the 2022 STI acquisition. Are there remaining intangibles tied to this business unit that could trigger further impairments, and what is the structural fix for the international segment?